Index by author

May 01, 2010; Volume 85,

From Bedside to Bench: The Role of Anti-Tumor Necrosis Factor Agents in the Management of Immune-Mediated Inflammatory Diseases

  1. Bernstein, CHARLES N.

    1. Epidemiology of Immune-Mediated Inflammatory Diseases: Incidence, Prevalence, Natural History, and Comorbidities
      HANI EL-GABALAWY, LYN C. GUENTHER and CHARLES N. BERNSTEIN
      The Journal of Rheumatology Supplement May 1 2010, 85 2-10; DOI: https://doi.org/10.3899/jrheum.091461

  2. Bressler, BRIAN

    1. Optimizing Use of Tumor Necrosis Factor Inhibitors in the Management of Immune-Mediated Inflammatory Diseases
      BRIAN BRESSLER, BOULOS HARAOUI, EDWARD KEYSTONE and ALESSANDRO SETTE
      The Journal of Rheumatology Supplement May 1 2010, 85 40-52; DOI: https://doi.org/10.3899/jrheum.091464

  3. El-gabalawy, HANI

    1. Pathophysiology and Pathogenesis of Immune-Mediated Inflammatory Diseases: Commonalities and Differences
      PROTON RAHMAN, ROBERT D. INMAN, HANI EL-GABALAWY and DENIS O. KRAUSE
      The Journal of Rheumatology Supplement May 1 2010, 85 11-26; DOI: https://doi.org/10.3899/jrheum.091462
    2. Epidemiology of Immune-Mediated Inflammatory Diseases: Incidence, Prevalence, Natural History, and Comorbidities
      HANI EL-GABALAWY, LYN C. GUENTHER and CHARLES N. BERNSTEIN
      The Journal of Rheumatology Supplement May 1 2010, 85 2-10; DOI: https://doi.org/10.3899/jrheum.091461

  4. Guenther, LYN C.

    1. Epidemiology of Immune-Mediated Inflammatory Diseases: Incidence, Prevalence, Natural History, and Comorbidities
      HANI EL-GABALAWY, LYN C. GUENTHER and CHARLES N. BERNSTEIN
      The Journal of Rheumatology Supplement May 1 2010, 85 2-10; DOI: https://doi.org/10.3899/jrheum.091461

  5. Haraoui, BOULOS

    1. From Bedside to Bench: The Role of Anti-Tumor Necrosis Factor Agents in the Management of Immune-Mediated Inflammatory Diseases
      BOULOS HARAOUI, ANTHONY S. RUSSELL and EDWARD C. KEYSTONE
      The Journal of Rheumatology Supplement May 1 2010, 85 1; DOI: https://doi.org/10.3899/jrheum.091460
    2. Optimizing Use of Tumor Necrosis Factor Inhibitors in the Management of Immune-Mediated Inflammatory Diseases
      BRIAN BRESSLER, BOULOS HARAOUI, EDWARD KEYSTONE and ALESSANDRO SETTE
      The Journal of Rheumatology Supplement May 1 2010, 85 40-52; DOI: https://doi.org/10.3899/jrheum.091464

  6. Inman, ROBERT D.

    1. Pathophysiology and Pathogenesis of Immune-Mediated Inflammatory Diseases: Commonalities and Differences
      PROTON RAHMAN, ROBERT D. INMAN, HANI EL-GABALAWY and DENIS O. KRAUSE
      The Journal of Rheumatology Supplement May 1 2010, 85 11-26; DOI: https://doi.org/10.3899/jrheum.091462

  7. Keystone, EDWARD

    1. Optimizing Use of Tumor Necrosis Factor Inhibitors in the Management of Immune-Mediated Inflammatory Diseases
      BRIAN BRESSLER, BOULOS HARAOUI, EDWARD KEYSTONE and ALESSANDRO SETTE
      The Journal of Rheumatology Supplement May 1 2010, 85 40-52; DOI: https://doi.org/10.3899/jrheum.091464

  8. Keystone, EDWARD C.

    1. From Bedside to Bench: The Role of Anti-Tumor Necrosis Factor Agents in the Management of Immune-Mediated Inflammatory Diseases
      BOULOS HARAOUI, ANTHONY S. RUSSELL and EDWARD C. KEYSTONE
      The Journal of Rheumatology Supplement May 1 2010, 85 1; DOI: https://doi.org/10.3899/jrheum.091460
    2. Tumor Necrosis Factor and Anti-Tumor Necrosis Factor Therapies
      EDWARD C. KEYSTONE and CARL F. WARE
      The Journal of Rheumatology Supplement May 1 2010, 85 27-39; DOI: https://doi.org/10.3899/jrheum.091463

  9. Krause, DENIS O.

    1. Pathophysiology and Pathogenesis of Immune-Mediated Inflammatory Diseases: Commonalities and Differences
      PROTON RAHMAN, ROBERT D. INMAN, HANI EL-GABALAWY and DENIS O. KRAUSE
      The Journal of Rheumatology Supplement May 1 2010, 85 11-26; DOI: https://doi.org/10.3899/jrheum.091462

  10. Rahman, PROTON

    1. Pathophysiology and Pathogenesis of Immune-Mediated Inflammatory Diseases: Commonalities and Differences
      PROTON RAHMAN, ROBERT D. INMAN, HANI EL-GABALAWY and DENIS O. KRAUSE
      The Journal of Rheumatology Supplement May 1 2010, 85 11-26; DOI: https://doi.org/10.3899/jrheum.091462
« Previous (Pages : 1 2 ... 2) Next »
Back to top

In this issue